AU7160691A - Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes - Google Patents

Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes

Info

Publication number
AU7160691A
AU7160691A AU71606/91A AU7160691A AU7160691A AU 7160691 A AU7160691 A AU 7160691A AU 71606/91 A AU71606/91 A AU 71606/91A AU 7160691 A AU7160691 A AU 7160691A AU 7160691 A AU7160691 A AU 7160691A
Authority
AU
Australia
Prior art keywords
idiotypes
infection
monoclonal antibodies
neutralize hiv
neutralize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71606/91A
Inventor
Nancy T. Chang
Tse Wen Chang
Michael S. C Fung
Bill N. C Sun
Cecily R. Y Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanox Inc
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of AU7160691A publication Critical patent/AU7160691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU71606/91A 1989-12-21 1990-12-19 Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes Abandoned AU7160691A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45416189A 1989-12-21 1989-12-21
US454161 1989-12-21
US53178990A 1990-06-12 1990-06-12
US531789 1990-06-12

Publications (1)

Publication Number Publication Date
AU7160691A true AU7160691A (en) 1991-07-24

Family

ID=27037357

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71606/91A Abandoned AU7160691A (en) 1989-12-21 1990-12-19 Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes

Country Status (2)

Country Link
AU (1) AU7160691A (en)
WO (1) WO1991009625A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007878A1 (en) * 1990-10-26 1992-05-14 The Public Health Research Institute Of The City Of New York, Inc. Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
WO1994004574A1 (en) * 1991-08-22 1994-03-03 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
US5618922A (en) * 1994-07-25 1997-04-08 Nissin Shokuhin Kabushiki Kaisha NM03 antibody materials and methods
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6193982B1 (en) 1995-04-27 2001-02-27 The United States Of America As Represented By The Department Of Health & Human Services Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
JP4307841B2 (en) 2001-03-22 2009-08-05 アメリカ合衆国 Glycosylation resistant cyanovirin and related conjugates, compositions, nucleic acids, vectors, host cells, methods of making and using non-glycosylated cyanovirins
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834976A (en) * 1986-07-03 1989-05-30 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
US4908203A (en) * 1987-09-09 1990-03-13 Johnson & Johnson Method for inducing HIV neutralizing antibodies using an internal image idiotope

Also Published As

Publication number Publication date
WO1991009625A1 (en) 1991-07-11

Similar Documents

Publication Publication Date Title
AU5267190A (en) Modified antibodies
IL99363A0 (en) Pharmaceutical compositions comprising homoconjugated monoclonal antibodies
AU4618193A (en) Humanized antibodies
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
HUT46062A (en) Process for producing human monoclonal antibody compositions protecting from bacterial infections and pharmaceutics comprising the same
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3330689A (en) Monoclonal antibodies
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
AU1022195A (en) Cytokine antibody for the treatment of sepsis
AU6036690A (en) Human monoclonal antibodies to hiv-1mn gp 120
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU6725190A (en) Anti-platelet monoclonal antibody
AU2383288A (en) Human anti-rh(d) monoclonal antibodies
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
AU8547291A (en) Monoclonal antibodies against tenascin
AU1820692A (en) Novel anti-hiv antibodies
AU2170692A (en) Me20: monoclonal antibodies and antigen for human melanoma
ZA903492B (en) T-lymphotropic retrovirus monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
GB8927389D0 (en) Monoclonal antibodies
AU3215189A (en) Monoclonal antibody against bone alkaline phosphatase
AU3432389A (en) Human monoclonal antibodies against rabies virus
AU7862291A (en) Modified antibodies
AU2546088A (en) Human monoclonal antibody against aspergilli